Nicola Low (UK)

Vincent CALVEZ (F), Christine KATLAMA (F), David LEWIS (ZA)

SY1-1 New treatments
Christine KATLAMA (F)

SY1-2 Primary and secondary HIV resistance to antiretrovirals
Vincent CALVEZ (F)

SY1-3 The use of pre and post-exposure prophylaxis to prevent the sexual transmission of HIV
Martin FISHER (UK)

SY1-4 Controlling the HIV epidemic in South Africa: future challenges
David LEWIS (ZA)

SY1-5 Male circumcision and the spread of HIV in Africa
Bertrand AUVERT (F)

Claudia HELLER-VITOUCH (A), Pieter van VOORST VADER (NL)

14h00
O.OO1 CAN WE RELIABLY DIAGNOSE SYPHILIS?
J. Scythes* - C. M. Jones - (Canada)

14h10
O.OO2 EVALUATION OF TREP-SURE ; A NEW FIRST LINE EIA FOR THE DETECTION OF TOTAL ANTI-TREPONEMAL ANTIBODIES
R. Notenboom* - M. Meddens - K. Nagy - (Canada, Hungary)

14h20
O.OO3 AFFINITY MATURATION OF SPECIFIC IGG ANTIBODIES IN SYPHILIS SEROLOGY
B. Schmidt* - (Austria)

14h30
O.OO4 RAPID TEST FOR SYPHILIS CONTROL IN PREGNANT WOMEN: A REALITY IN RURAL AREAS OF BOLIVIA
F. Tinajeros* - S. Garcia - R. Revollo - C. Diaz - D. Grossman - B. Adele - (Bolivia, Brazil, Mexico, USA)

14h40
O.OO5 CLINICAL FEATURES OF CONGENITAL SYPHILIS IN BELARUS
O. Pankratov* - (Belarus)

14h50
O.OO6 GENITAL ULCERATIONS : A PROSPECTIVE STUDY OF 280 CASES (1995-2005)
V. Anyfantakis* - P. Bonhomme - J. Louison - T. Tandeau de Marsac - B. Chaine - P. Vallée - I. Casin - C. Scieux - F. Lassau - M. Janier (France)

15h00
O.OO7 A RETROSPECTIVE STUDY OF 24 CASES OF SYMPTOMATIC NEUROSYPHILIS; DECLARED BETWEEN 2000 TO 2005 IN A DEPARTMENT OF INFECTIOUS AND TROPICAL DISEASES
E. Hope-Rapp* - A. Canestri - L. Paris - F. Bricaire - P. Le Hoang - E. Caumes - (France)

15h10
O.OO8 ENHANCED SURVEILLANCE OF AN OUTBREAK OF SYPHILIS IN TURIN
S. Delmonte* - M. Bernengo - S. Rondoletti - (Italy)

15h20
O.OO9 LARGE HETEROSEXUAL SYPHILIS OUTBREAK IN THE REGION OF AACHEN, GERMANY
U. Marcus* - O. Hamouda - V. Bochat - (Germany)

Fabrice BOUSCARAT (F), Mihael SKERLEV (HR), Jane STERLING (UK)

SY2-1 Genital warts : clinical and therapeutic problems in HIV-negative and HIV-positive patients
Fabrice BOUSCARAT (F)

SY2-2 HPV genital infections in males : clinical aspects and the sense of the HPV-DNA typing
Mihael SKERLEV (HR)

SY2-3 A quantified green tea extract in the treatment of external ano-genital warts
Gerd GROSS (D)

SY2-4 Is vaccination the answer for HPV infection ?
Jane STERLING (UK)

SY2-5 HPV, anal intraepithelial neoplasia and carcinoma in MSM
Joel PALEFSKY (USA)

Establishing Meeting of the Network of Sexual and Reproductive Health and Rights for Countries of Central and Eastern Europe, Central Asia and Western Balkans

Chair:

Marius DOMEIKA (SE)

NEW HOPE FOR HEPATITIS B PATIENTS

Christine Katlama (F)

16h00
SS1-1 Natural history, epidemiology and transmission of the HBV virus
Stanislas Pol (F)

16h20
SS1-2 Place of entecavir in the management of chronic hepatitis B in naive patients
Marc Bourlière (F)

16h40
SS1-3 Management of chronic hepatitis B, in HBV/HIV co-infected patients: place of entecavir
Yves Benhamou (F)

17h
SS1-4 Questions-Answers

Keith William RADCLIFFE (UK), Pieter van VOORST VADER (NL)

GUI-1 Management of gonorrhea
Chris BIGNELL (UK)

GUI-2 How can we optimise the management of women with gonococcal pelvic inflammatory disease
Jonathan ROSS (UK)

GUI-3 Syphilis Management in Europe: 2006 update of syphilis guideline IUSTI/WHO Europe 2001
Pieter van VOORST VADER (NL)

GUI-4 Management of proctitis
Henry de VRIES (NL)

Keith William RADCLIFFE (UK), Airi PODER (EST), Angelika STARY (A), Willem I. van der MEIJDEN (NL), Michel JANIER (F)

Jean CIVATTE (F)

OL1 Ethical Issues in French 19th century Venereology
Daniel WALLACH (F)

OL2 Morbus gallicus to HIV. Aspects of the History of Europe
Michael WAUGH (UK)

Sevgi ARAL (USA), Tom COENEN (NL), Christian DERANCOURT (F)

SY3-1 Social epidemiology of STDs including social determinants in the context of globalisation
Helen WARD (UK)

SY3-2 Unintended consequences of STD/HIV interventions including deshinibition
Sevgi ARAL (USA)

SY3-3 Alarming trends: increases in STD/HIV incidence among MSM and paid for sex
Kevin FENTON (USA)

SY3-4 Intervention impacts dependence on socio-epidemiologic context and target groups
Geoff GARNETT (UK)

Sallie NEILL (UK), Willem I. van der MEIJDEN (NL), Monique PELISSE (F)

SY4-1 VIN diagnosis and management
Sallie NEILL (UK)

SY4-2 Vulvodynia: a brief overview
Willem I. van der MEIJDEN (NL)

SY4-3 Surgical treatment of male-to-female transsexuals : a ten year experience assessment
Marc REVOL (F)

SY4-4 Male dyspareunia and the dysfunctional foreskin
Chris BUNKER (UK)

SY4-5 Designer genitals/genital adornments
Eva DURAY (UK)

Bertille de BARBEYRAC (F), Caroline SEMAILLE (F), Angelika STARY (A)

8h30
O.010 CLINICAL PRESENTATION AND CONSEQUENCES OF CHLAMYDIA TRACHOMATIS (PLACENTAL) INFECTION IN PRETERM DELIVERY
G. Rours* -  A. Ott -  L. J. I. Zimmerman -  R. Kornelissen -  R. de Groot -  H. A. Verbrugh -  R. P. Verkooijen - (The Netherlands)

8h40
O.011 ASSOCIATION OF FECUNDITY AND UROGENITAL CHLAMYDIA TRACHOMATIS INFECTION IN A HISTORICAL COHORT OF DANISH FEMALES BORN IN 1971
L. Svehag* -  J. Møller - (Denmark)

8h50
O.012 C TRACHOMATIS: LABORATORY DIAGNOSIS IN NEW ZEALAND- THE EXPECTATION (NAAT); THE FUNDING (EIA); HOW TO MERGE AND MANAGE THE BEST OF BOTH TECHNOLOGIES
M. McCarthy* - (New Zealand)

9h00
O.013 COMPARISON OF SPECIMEN TYPE ACCURACY FOR TESTING BY NUCLEIC ACID AMPLIFICATION TESTS AND PATIENT SPECIMEN PREFERENCE FOR DETECTION OF CHLAMYDIA TRACHOMATIS (CT) AND NEISSERIA GONORRHOEAE (GC) IN WOMEN ATTENDING SEXUALLY TRANSMITTED DISEASE CLINICS
C. Gaydos* -  N. Maldeis -  A. Hardick -  J. Hardick -  M. Barnes -  B. Wood - (USA)

9h10
O.014 ADEQUACY OF SELF-COLLECTED VAGINAL SAMPLES FOR THE DETECTION OF CHLAMYDIA TRACHOMATIS  SCREENING PROGRAMS: APPLICATION OF QUANTITATIVE PCR
B. de Barbeyrac* -  S. Raherison -  M. Clerc -  F. Jeanson -  M. C. Marsol -  C. Mathieu -  C. Hocké -  C. Bébéar - (France)

9h20
O.015 SCREENING FOR GENITAL C. TRACHOMATIS INFECTION IN UNIVERSITY STUDENTS USING MAILED URINE SAMPLES
S. Sylvan* -  L. Oscarsson -  A. Hallen -  E. Hjelm -  M. Domeika - (Sweden)

9h30
O.016 NATIONAL CHLAMYDIA SCREENING PROGRAMME (NCSP) IN ENGLAND: PATIENT MANAGEMENT AND PARTNER NOTIFICATION
M. Macintosh* -  S. Randall -  J. Clarke -  L. Emmett -  A. Talebi -  V. Delpech - (United Kingdom)

9h40
O.017 CHLAMYDIA TRACHOMATIS HOME SCREENING IN A FRENCH NATIONAL POPULATION-BASED SURVEY ON SEXUAL ATTITUDE. PRELIMINARY RESULTS
V. Goulet* -  J. Warszawski -  B. de Barbeyrac -  C. Salé -  S. Raherison -  N. Beltzer -  M. Bozon -  N. Bajos -  C. S. F. Group - (France)

9h50
O.018 CHLAMYDIA SCREENING IN THE UNITED STATES: WHERE ARE WE NOW?
C. Lindsey Satterwhite - (United States)

Angelika STARY (A), Patrice MOREL (F), Julius SCHACHTER (USA)

PL1 PLENARY LECTURE 1 Epidemiology of STIs and HIV Infection: the European Perspective
Keith William RADCLIFFE (UK)

PL2 PLENARY LECTURE 2 Skin Manifestations and HIV Infection
Toby MAURER (USA)

PL3 PLENARY LECTURE 3 Chlamydia Screening in Europe: do we Know where we are going ?
Nicola LOW (UK)

Advances in Nucleic Acid Amplification Assays for the Detection of STIs
Chair: Julius Schachter ( USA)

Screening for Chlamydia trachomatis: Which tests, which specimens, and can you have confidence in the results?
Julius Schachter (USA)
Detection of chlamydial and gonococcal infections in men and women by using alternative noninvasive specimens.
Angelika Stary (A)
Comparing nucleic acid amplification tests on liquid Pap and self-collected genital samples.
Max Chernesky (CA)

Isabelle CASIN (F), Joergen Skov JENSEN (DK), Harald MOI (N)

SY5-1 Use of Molecular Methods to Better Understand the Micro Ecology of the Vagina
David MARTIN (USA)

SY5-2 Heterogeneity of the mgpB and mgpC Genes in Mycoplasma genitalium – a mechanism for persistence in vivo?
Patricia TOTTEN (USA)

SY5-3 The role of Mycoplasma genitalium in pelvic inflammatory disease
Catherine HAGGERTY (USA)

SY5-4 U. urealyticum and U. parvum in men with and without urethritis
Amir MOGHADDAM (N)

Vincent PIGUET (CH), Anne BIANCHI (F)

SY6-1 Topical microbicides: what they do and why we need them
Electra NICOLAIDOU (GR)

SY6-2 Exploiting HIV weakness at its point of entry across mucosal epithelia
Vincent PIGUET (CH)

SY6-3 Discovery and development of chemokine analogues as topical microbicides
Olivier HARTLEY (CH)

SY6-4 Topical microbicides in the prevention of STIs and HIV
Lawrence STANBERRY (USA)

SY6-5 Discovery , preclinical and clinical development of SPL 7013 Gel (VivaGel®), a dendrimer based microbicide for HIV and HSV-2 prevention
Tom McCARTHY (AUS)

Derek FREEDMAN (IRL), Marti VALL MAYANS (SP)

14h00
O.019 PERSISTENCE OF SYPHILIS INCIDENCE IN MEN WHO HAVE SEX WITH MEN AND INCREASE IN CHLAMYDIA DIAGNOSES AMONG YOUNG WOMEN – BELGIUM 2005
A. Defraye* -  A. Sasse - (Belgium)

14h10
O.020 SEXUALLY TRANSMITTED INFECTIONS (STI) IN CANADA: 1996-2005
M. Gully* -  M. Perrin -  T. Wong - (Canada)

14h20
O.021 PREVALENCE OF SEROLOGICAL MARKERS OF HEPATITIS C VIRUS AMONG MEN WHO HAVE SEX WITH MEN (MSM) IN MADRID, 2003-2005
J. Del Romero* -  C. Rodríguez -  D. Rojas -  J. Ballesteros -  P. Clavo -  J. Castilla (Spain)

14h30
O.022 SURGICAL MANAGEMENT OF ACUTE EPIDIDYMO-ORCHITIS - TOO BIG A PUBLIC HEALTH RISK?
N. Jayatilaka* - J. Phillips - G. R. Kinghorn - T. Gillam - J. Goring - (United Kingdom)

14h40
O.023 CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF ACQUIRED SYPHILIS IN CHILDREN IN MINSK (BELARUS)
V. Pankratov -  O. Pankratov* -  E. Shishkina - (Belarus)

14h50
O.024 SEXUALLY TRANSMITTED INFECTIONS IN FEMALE SEX WORKERS IN GERMANY – RESULTS OF THE STI SENTINEL SURVEILLANCE
V. Bremer* -  U. Marcus -  A. Hofmann -  O. Hamouda - (Germany)

15h00
O.025 CHARACTERISTICS AND STI/HIV PREVALENCE AMONG MIGRANT COMMERCIAL SEX WORKERS (CSW) IN LIMA, PERU
E. Hsieh* -  J. R. Zunt -  S. M. Montano -  E. Quijano -  V. Solari - (Peru, United States)

15h10
O.026 HPV IMMUNISATION CHALLENGES: PARALLELS WITH A HEPATITIS B VACCINE PILOT PROGRAMME
L. Wallace* -  J. C. Cameron -  S. Ahmed -  D. J. Goldberg - (United Kingdom)

15h20
O.027 ASYMPTOMATIC QUICK CHECK CLINICS…A WAY FORWARD
H. Jaleel* -  D. Evans -  A. Keefe - (United Kingdom)

Chairs: Angelika Stary (A), Bernard Branson (USA)

16h00
SS3-1 A new point-of-care test for Chlamydia
Helen H. Lee (UK)

16h10
SS3-2 Chlamydia Rapid Test: Clinical trial data from the UK
Beng Goh (UK)

16h25
SS3-3 Issues on Chlamydia testing and treatment in a young people’s sexual health centre
Penny Barber (UK)

16h40
SS3-4 STI in the Philippines
Francis Saison (PH)

16h55
SS3-5 Utility of rapid tests in resourcelimited Settings
Jean-Pierre Allain (UK)

17h10
SS3-6 CDC’s New HIV testing recommendations for health care settings
Bernard Branson (USA)

Lawrence STANBERRY (USA), Isabelle BOURGAULT (F), Raj PATEL (UK)

SY7-1 Vaccines against Human Papilloma Virus
Isabelle BOURGAULT (F)

SY7-2 Herpes vaccines
Lawrence STANBERRY (USA)

SY7-3 HIV vaccines: review and prospects
Pierre VANDEPAPELIERE (B)

SY7-4 Vaccine Acceptability in Adolescents
Susan ROSENTHAL (USA)

Simon BARTON (UK), Marco CUSINI (I), Mikhail GOMBERG (RU)

SY8-1 Ethics, particularly in relation to STIs and HIV and criminalising their transmission
James BINGHAM (UK)

SY8-2 Criminalizing STIs and HIV - Legal issues
Andrea GENTILOMO (IT)

SY8-3 Ethical conundrums of criminalisation
Andrew LAWSON (UK)

SY8-4 Patient Advocacy View
Lisa POWER (UK)

Christine KATLAMA (F), Airi PODER (EST), Marc VANDENBRUAENE (B)

8h30
O.028 WHAT IS THE EXTENT OF FAMILY DOCTOR INVOLVEMENT IN THE CARE OF HIV PATIENTS IN THE UK?
H. Evans* - J. Cassell - C. H. Mercer - G. Brook - G. Hughes - G. Rait - I. Petersen - I. Simms - V. Delpech - T. Chadborn - M. Hamill - S. Singh - A. Islam - A. M. Johnson - (United Kingdom)

8h40
O.029 WHO IS GETTING INFECTED WITH HIV? RECENT SEROCONVERTERS FROM AN HIV/STI CLINIC OF MADRID, SPAIN (2000-2005)
D. Rojas* - J. Del Romero - C. Rodríguez - R. Belliard - S. García - J. Belmar - (Spain)

8h50
O.030 FAILURE TO RETURN FOR HIV TEST RESULTS AND COUNSELING IN AN STI CLINIC POPULATION
M. Vall-Mayans* - C. Manzardo - M. Saravanya - N. Trota - E. Loureiro - (Spain)

9h00
O.031 SEXUAL BEHAVIOUR AND WILLINGNESS TO TAKE PEPSE
S. De Silva* - M. Hamill - R. Miller - J. Walsh - (United Kingdom)

9h10
O.032 FEMALE GENITAL CIRCUMCISION AND THE RISK OF HIV INFECTION AMONG THE KIKUYU PEOPLE OF KENYA: A PROPENSITY SCORES ANALYSIS
A. Hadgu* - G. E. Kiros - M. Sternberg - (United States)

9h20
O.033 DOES PERIODIC PRESUMPTIVE THERAPY WITH AZITHROMYCIN AFFECT THE PREVALENCE OF STI AND HIV IN HIGH RISK WOMEN?
I. Zietsman - C. Pillay - Y. Mzaidume - F. Radebe - D. A. Lewis* - (South Africa)

9h30
O.034 INCREASED REPLICATION OF HIV-1 DURING GENITAL HERPES EPISODES AMONG WOMEN IN GHANA AND CENTRAL AFRICAN REPUBLIC (ANRS 1212 STUDY)
J. LeGoff* - G. Gresenguet - H. Weiss - N. Khonde - E. Frost - H. Bouhlal - C. Chemin - T. Agyarko-Poku - C. Asamoah-Adu - J. Longo - J. Malkin - R. Hayes - D. Mabey - J. Pepin - P. Mayaud - L. Belec - (Canada, Central African Republic, France, Ghana, United Kingdom)

9h40
O.035 IMPACT OF HSV-2 EPISODIC THERAPY ON HIV-1 AND HSV-2 GENITAL SHEDDING AND ULCER HEALING AMONG WOMEN IN GHANA AND THE CENTRAL AFRICAN REPUBLIC: RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (ANRS 1212 STUDY)
L. Belec* - G. Gresenguet - N. Khonde - H. Weiss - J. LeGoff - E. Frost - H. Bouhlal - C. Chemin - J. Longo - T. Agyarko-Poku - C. Asamoah-Adu - J. Malkin - R. Hayes - D. Mabey - J. Pepin - P. Mayaud - (Canada, Central African Republic, France, Ghana, United Kingdom)

9h50
O.036 MYCOPLASMA FERMENTANS AND MYCOPLASMA PENETRANS IN PATIENTS INFECTED WITH HIV 1 AND/OR HIV 2 FROM A PORTUGUESE HOSPITAL
D. Domingues* - F. Nogueira - L. Tavira - R. Camacho - F. Exposto - (Portugal)

Michel JANIER (F), Mihael SKERLEV (HR), Willem I. van der MEIJDEN (NL)

PL4 PLENARY LECTURE 4 STIs in MSMs
Sébastien FOUERE (F)

PL5 PLENARY LECTURE 5 HSV/HIV: double virus, double trouble
Anna WALD (USA)

PL6 PLENARY LECTURE 6 Training in Venereology – towards a European programme
James BINGHAM (UK)

Innovation for syphilis control and prevention: Promises and challenges

12h15
SS4-1 Current Syphilis Situation in Europe
Ulrich Laukamm-Josten (CH)

12h30
SS4-2 Evaluation of Rapid Syphilis Tests
Rosanna W. Peeling (CH)

12h45
SS4-3 Strategies for Syphilis Control: Lessons from the Developing World
David Mabey (UK)

13h05
SS4-4 Syphilis Control in the 21st Century
King Holmes (USA)

13h25
SS4-5 Discussion

Ulrich MARCUS (D), Kees RIETMEIJER (USA), Chantal VERNAY-VAISSE (F)

SY9-1 Putting sex back into STI prevention
J. Dennis FORTENBERRY (USA)

SY9-2 Sexual networks and STI prevention
Jonathan M. ELLEN (USA)

SY9-3 Integrating prevention counseling in STI/HIV pratice: the time has come
Kees RIETMEIJER (USA)

SY9-4 Ask, screen, intervene: prevention with HIV-infected persons in STI/HIV care settings
Mark THRUN (USA)

Eric CAUMES (F), Nicolas DUPIN (F), Reinhard HOPFL (A)

SY10-1 Anal HPV in HIV infected patients
Christophe PIKETTY (F)

SY10-2 The anorectal lymphogranuloma venereum (LGV) epidemic among MSM
Henry de VRIES (NL)

SY10-3 Sexually transmitted infections and hepatitis viruses
Stanislas POL (F)

SY10-4 Genital Herpes and HIV transmission
Anne BUVE (B)

SY10-5 Syphilis and HIV Infection
Eric CAUMES (F)

David BARLOW (UK), Peter KOHL (D)

14h00
O.037 CLINICAL VALIDATION OF A REAL-TIME PCR DETECTION OF NEISSERIA GONORRHOEAE PORA VS CULTIVATION BASED TECHNIQUES
S. Hjelmevoll* -  M. Olsen -  J. Ericson Sollid -  H. Haaheim -  M. Unemo -  K. Melby -  H. Moi -  V. Skogen - (Norway, Sweden)

14h10
O.038 CAN ANTIBIOTIC RESISTANCE IN NEISSERIA GONORRHOEAE BE PREDICTED BY MOLECULAR TYPING USING NG-MAST?
H. Young* -  H. Palmer - (United Kingdom)

14h20
O.039 USE OF THE GEN-PROBE APTIMA COMBO 2 ASSAY TO DIAGNOSE NEISSERIA GONORRHOEAE INFECTIONS FROM A VARIETY OF SITES: - COMPARISON WITH MICROBIOLOGY CULTURE RESULTS
P. Lowe* -  P. O'Loughlin -  D. Drummond -  R. Vohra -  P. Bartley - (Australia)

14h30
O.040 THE PERFORMANCE OF ORAL-THROAT RINSES AS A NOVEL APPROACH TO DETECT PHARYNGEAL NEISSERIA GONORRHOEAE (GC) AND CHLAMYDIA TRACHOMATIS (CT) INFECTIONS.
J. Papp* -  K. Ahrens -  C. Philips -  C. Farshy -  C. K. Kent -  J. D. Klausner - (United States)

14h40
O.041 FLUOROQUINOLONE RESISTANT STRAINS OF NEISSERIA GONORRHOEAE (NG) IN PARIS (FRANCE): RISING INCIDENCE AND THERAPEUTIC IMPLICATIONS
F. Lassau* -  I. Casin -  B. Grandry -  M. Janier - (France)

14h50
O.042 BEHAVIORAL RISK FACTORS AS A CAUSE OF NON-CHLAMYDIAL NON-GONOCOCCAL URETHRITIS
M.A. Gomberg, V.P. Kovalyk (Russian Federation)

15h00
O.043 LABORATORY DIAGNOSIS OF NON-VIRAL SEXUALLY TRANSMITTED INFECTIONS (STIs) IN ST PETERSBURG, RUSSIA
M. Domeika* -  I. Litvinenko -  T. Smirnova -  O. Gaivoronskaya -  A. Savicheva -  M. Unemo - (Russian Federation, Sweden)

15h10
O.044 OUTBREAK OF RECTAL LYMPHOGRANULOMA VENEREUM (LGV) IN FRANCE
B. de Barbeyrac* -  M. Herida -  G. Kreplak -  N. Lemarchand -  P. Sednaoui -  C. Scieux -  M. Clerc -  V. Goulet -  C. Bébéar -  C. Semaille - (France)

15h20
O.045 DOXYCYCLINE TREATMENT FOR LYMPHOGRANULOMA VENEREUM PROCTITIS: CLINICAL AND MICROBIOLOGICAL RESPONSES
J. White* -  C. Y. W. Tong -  H. Ward -  C. Ison - (United Kingdom)

Henry de VRIES (NL), Eric FLEUTELOT (F), Ulrich MARCUS (D)

16h00
O.046 AGE BRIDGING AMONG YOUNG, URBAN HETEROSEXUAL MEN INFECTED WITH CHLAMYDIA TRACHOMATIS (CT)
J. Jennings* -  R. F. Luo -  L. V. Lloyd -  C. Gaydos -  J. M. Ellen -  C. A. Rietmeijer - (United States)

16h10
O.047 SEXUAL RISK TAKING AND SEXUAL HEALTH SEEKING BEHAVIOUR AMONG YOUTH IN THE BALKANS
W. Delva* -  F. Wuillaume -  P. Claeys -  M. Temmerman - (Belgium)

16h20
O.048 THE GUM / PAEDIATRIC INTERFACE
C. Thompson* - (United Kingdom)

16h30
O.049 SOCIAL, BEHAVIOURAL, AND INTERVENTION RESEARCH AMONG AFRICAN COMMUNITIES AFFECTED BY HIV: A SCOPING REVIEW
A. Prost* - (United Kingdom)

16h40
O.050 SEXUAL BEHAVIOUR, HIV TESTING, SERVICE USE AND SAMPLE HIV POSITIVITY AMONG A COMMUNITY-SAMPLE OF BLACK AFRICANS IN ENGLAND: MAYISHA II.
K. Sadler* -  G. Elam -  C. McGarrigle -  W. Ssanyu-Sseruma -  M. Ndebele -  P. Serugga -  G. Othieno -  O. Davidson -  J. V. Parry -  D. Mercey -  K. A. Fenton - (United Kingdom)

16h50
O.051 INTEGRATING STD/RTI CARE INTO PRIMARY HEALTH CARE AS NEW STI/AIDS SERVICE MODEL IN HIGH RISK POPULATION IN URBAN AREAS OF CHINA
L. Zhang* -  X. X. C. Wang -  A. A. van den Hoek - (China, The Netherlands)

17h00
O.052 SEXUAL BEHAVIOR AND TOXIC HABITS IN MSM NON-IDUS WITH HCV INFECTION FROM AN HIV/STI CLINIC IN MADRID, SPAIN (2004-2005)
D. Rojas* -  J. Del Romero -  C. Rodríguez -  S. García -  J. Ballesteros -  P. Clavo - (Spain)

17h10
O.053 SEXUAL BEHAVIOUR AND CHARACTERISTICS OF CLIENTS OF FEMALE SEX WORKERS IN SWITZERLAND
F. Dubois-Arber* -  H. Balthasar -  A. Jeannin -  G. Meystre-Agustoni - (Switzerland)

17h20
O.054 REACHING BEHAVIOURAL RISK GROUPS FOR HEPATITIS B VACCINATION BY OUTREACH ACTIVITIES
M. Heijnen* -  Q. Waldhober -  H. Driessen -  M. de Wit -  M. de Vries - (The Netherlands)

17h30
O.055 REACHING BEHAVIOURAL RISK GROUPS FOR HEPATITIS B VACCINATION IN PRISON
Q. Waldhober* -  M. Heijnen -  R. Wolter -  G. van 't Hoff -  M. de Vries - (The Netherlands)

17h40
O.056 REDUCING THE “SEX IS BETTER WITHOUT THEM” BARRIER TO CONDOM USE
S. Perdue* -  R. N. Shain -  A. E. C. Holden -  J. M. Piper - (United States)

17h50
O.057 REASONING FOR NOT HAVING USED CONDOMS AND CONDITIONS FOR GIVING UP CONDOM USE IN ANAL INTERCOURSE IN A COMMUNITY SAMPLE OF HIV NEGATIVE OR UNTESTED GAY MEN FROM BERLIN
U. Marcus* -  A. J. Schmidt -  O. Hamouda - (Germany)

Michel JANIER (F), Mihael SKERLEV (HR), Willem I. van der MEIJDEN (NL)